Volume 28, Issue 1 (Avicenna Journal of Clinical Medicine-Spring 2021)                   Avicenna J Clin Med 2021, 28(1): 28-35 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Tabasi Z, Mesdaghinia E, Abedzadeh-Kalahroudi M, Akbari H, Bandagi-Motlagh M. Maternal and Neonatal Outcomes in Expectant Management of Early-Onset Severe Preeclampsia. Avicenna J Clin Med. 2021; 28 (1) :28-35
URL: http://sjh.umsha.ac.ir/article-1-2200-en.html
1- Associate Professor, Department of Obstetrics and Gynecology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
2- Associate Professor, Trauma Nursing Research Center, Kashan University of Medical Sciences, Kashan, Iran , abedzadeh@kaums.ac.ir
3- Associate Professor, Department of Statistics and Epidemiology, Faculty of Health, Kashan University of Medical Sciences, Kashan, Iran
4- 4 General Practitioner, Kashan University of Medical Sciences, Kashan, Iran
Abstract:   (687 Views)
Background and Objective: Preeclampsia is one of the most critical complications of pregnancy observed in 2%-8% of all pregnancies. Severe preeclampsia has many maternal and neonatal complications that are more prevalent in early-onset preeclampsia. The present study aimed to determine the prevalence of maternal and neonatal outcomes of expectant management of severe preeclampsia before 34 weeks of gestation.
Materials and Methods: In this retrospective descriptive study, the medical records of 55 mothers who had severe preeclampsia before 34 weeks of gestation and underwent expectant management and those of their neonates within 2014-2019 in Kashan, Iran, were reviewed. The information extracted from the medical records included maternal and neonatal demographic variables and outcomes. All data were analyzed in SPSS software (version 16) using descriptive and inferential statistics. The p-values of less than 0.05 were considered significant.
Results: In this study, the rates of seizure, post-partum hemorrhage, intensive care unit admission, and platelet decline were 5.5%, 1.8%, 3.6%, and 7.3%, respectively. Moreover, 10.9% of mothers had renal failure, and therefore, elevated liver enzymes and hemolysis. Among the neonates, 44.7% and 12.7% of the cases had respiratory distress syndrome (RDS) and low Apgar scores, respectively. It was also revealed that 6.4% of the neonates had convulsions and pneumothorax (PTX), and neonatal mortality was observed in 6.4% of them. No significant relationship was observed between maternal outcomes and gestational age and between neonatal outcomes and the number of deliveries (P>0.05). However, renal failure outcomes had a significant relationship with the number of deliveries (P=0.023), meaning that all mothers with renal failure were nulliparous. It was found that gestational age had a  significant relationship with the outcomes of neonatal death, low 5-minute Apgar score, low birth weight, RDS, and PTX (P<0.05); in other words, lower gestational age led to higher mentioned neonatal outcomes.
Conclusion: Expectant management of early-onset preeclampsia was beneficial for neonates, and the implementation of regular and close monitoring in equipped centers would prevent the increase of maternal complications.
 
Full-Text [PDF 1193 kb]   (264 Downloads)    
Type of Study: Original | Subject: Obstetrics & Gynecology

References
1. Curiel-Balsera E, Prieto-Palomino M, Munoz-Bono J, de Elvira MR, Galeas J, García GQ. Analysis of maternal morbidity and mortality among patients admitted to Obstetric Intensive Care with severe preeclampsia, eclampsia or HELLP syndrome. Med Intensiva. 2011;35(8):478-83. PMID: 21703718 DOI: 10.1016/j.medin.2011.05.011
2. Jeyabalan A. Epidemiology of preeclampsia: impact of obesity. Nutr Rev. 2013;71(Suppl 1):S18-25. PMID: 24147919 DOI: 10.1111/nure.12055
3. Rylander R. Pre-eclampsia during pregnancy and cardiovascular disease later in life: the case for a risk group. Arch Gynecol Obstet. 2015;292(3):519-21. PMID: 25721023 DOI: 10.1007/s00404-015-3676-3
4. Kharaghani R, Cheraghi Z, Esfahani BO, Mohammadian Z, Nooreldinc RS. Prevalence of preeclampsia and eclampsia in Iran. Arch Iranian Med. 2016;19(1)64-71. PMID: 26702751
5. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066-74. PMID: 16581405 DOI: 10.1016/S0140-6736(06)68397-9
6. Lisonkova S, Joseph K. Incidence of preeclampsia: risk factors and outcomes associated with early-versus late-onset disease. Am J Obstet Gynecol. 2013;209(6):544.e1-12. PMID: 23973398 DOI: 10.1016/j.ajog.2013.08.019
7. Publications Committee, Society for Maternal-Fetal Medicine, Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am J Obstet Gynecol. 2011;205(3):191-8. PMID: 22071049 DOI: 10.1016/j.ajog.2011.07.017
8. Alvarez RN, Marin R. Severe maternal complications associated with pre-eclampsia: an almost forgotten pathology? Nefrologia. 2001;21(6):565-73. PMID: 11881426
9. Churchill D, Duley L, Thornton JG, Moussa M, Ali HS, Walker KF. Interventionist versus expectant care for severe pre‐eclampsia between 24 and 34 weeks' gestation. Cochrane Database Syst Rev. 2018;10(10):CD003106. PMID: 30289565 DOI: 10.1002/14651858.CD003106.pub3
10. Bernardes T, Zwertbroek E, Broekhuijsen K, Koopmans C, Boers K, Owens M, et al. Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta‐analysis. Ultrasound Obstet Gynecol. 2019;53(4):443-53. PMID: 30697855 DOI: 10.1002/uog.20224
11. Magee L, Yong P, Espinosa V, Cote A, Chen I, Von Dadelszen P. Expectant management of severe preeclampsia remote from term: a structured systematic review. Hypertens Pregnancy. 2009;28(3):312-47. PMID: 19277923 DOI: 10.1080/10641950802601252
12. Cunningham F, Leveno K, Bloom S, Dashe J, Spong C, Hauth J, et al. Williams obstetrics. 25th ed. New York: McGraw-Hill Education; 2018.
13. Kartikadewi R, Theresia EM, Meilani N. Age, parity and birth spacing to the incidence of preeclampsia. Int J Public Health Sci. 2019;8(1):45-50. DOI: 10.11591/ijphs.v8i1.16646
14. Opitasari C, Andayasari L. Parity, Education level and risk for (pre-) eclampsia in selected hospitals in Jakarta. Health Sci J Indonesia. 2014;5(1):35-9.
15. Vigil-De Gracia P, Tejada OR, Miñaca AC, Tellez G, Chon VY, Herrarte E, et al. Expectant management of severe preeclampsia remote from term: the MEXPRE Latin Study, a randomized, multicenter clinical trial. Am J Obstet Gynecol. 2013;209(5):425.e1-8. PMID: 23954534 DOI: 10.1016/j.ajog.2013.08.016
16. Abdel-Hady ES, Fawzy M, El-Negeri M, Nezar M, Ragab A, Helal AS. Is expectant management of early-onset severe preeclampsia worthwhile in low-resource settings? Arch Gynecol Obstet. 2010;282(1):23-7. PMID: 19693521 DOI: 10.1007/s00404-009-1209-7
17. Bombrys AE, Barton JR, Nowacki EA, Habli M, Pinder L, How H, et al. Expectant management of severe preeclampsia at less than 27 weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Obstet Gynecol. 2008;199(3):247.e1-6. PMID: 18771971 DOI: 10.1016/j.ajog.2008.06.086
18. Guida JPS, Surita FG, Parpinelli MA, Costa ML. Preterm preeclampsia and timing of delivery: a systematic literature review. Rev Bras Ginecol Obstet. 2017;39(11):622-31. PMID: 28701023 DOI: 10.1055/s-0037-1604103
19. Sibai BM, Barton JR. Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol. 2007;196(6):514.e1-9. PMID: 17547875 DOI: 10.1016/j.ajog.2007.02.021
21. 20. Wang Y, Hao M, Sampson S, Xia J. Elective delivery versus expectant management for pre-eclampsia: a meta-analysis of RCTs. Arch Gynecol Obstet. 2017;295(3):607-22. PMID: 28150165 DOI: 10.1007/s00404-016-4281-9
22. Nisell H, Palm K, Wolff K. Prediction of maternal and fetal complications in preeclampsia. Acta Obstet Gynecol Scand. 2000;79(1):19-23. PMID: 10646811
23. Bombrys AE, Barton JR, Habli M, Sibai BM. Expectant management of severe preeclampsia at 27 (0/7) to 33 (6/7) weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Perinatol. 2009;26(6):441-6. PMID: 19288398 DOI: 10.1055/s-0029-1214243
24. Boutin A, Guerby P, Gasse C, Tapp S, Bujold E. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study. Am J Obstet Gynecol. 2021;224(2):204.e1-7. PMID: 32777265 DOI: 10.1016/j.ajog.2020.08.008
25. Ndoni E, Hoxhallari R, Bimbashi A. Evaluation of maternal complications in severe preeclampsia in a university hospital in Tirana. Open Access Macedonian J Med Sci. 2016;4(1):102-6. PMID: 27275340 DOI: 10.3889/oamjms.2016.025
26. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol. 1994;171(3):818-22. PMID: 8092235 DOI: 10.1016/0002-9378(94)90104-x
27. Swamy M, Patil K, Nageshu S. Maternal and perinatal outcome during expectant management of severe pre-eclampsia between 24 and 34 weeks of gestation. J Obstet Gynecol India. 2012;62(4):413-8. PMID: 23904701 DOI: 10.1007/s13224-012-0293-y
28. Vijayan N, Keepanasseril A, Plakkal N, Udupa V, Raghavan S. Maternal and perinatal outcomes in women undergoing expectant management of early-onset pre-eclampsia: A retrospective cohort study. South Afr J Obstet Gynaecol. 2018;24(3):83-6. DOI: 10.7196/sajog.1378
29. Marcdante K, Kliegman RM. Nelson essentials of pediatrics. 8th ed. New York: Elsevier Health Sciences; 2019. P. 242
30. Haddad B, Deis S, Goffinet F, Paniel BJ, Cabrol D, Sibaı̈ BM. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation. Am J Obstet Gynecol. 2004;190(6):1590-5. PMID: 15284743 DOI: 10.1016/j.ajog.2004.03.050

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Avicenna Journal of Clinical Medicine

Designed & Developed by : Yektaweb